← All stocks

Insight Molecular Diagnostics Inc.

IMDX Net buying
CIK 0001642380 #4159 in the set updated 17 Sep 2026
Bought (120 mo)
$125.34M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$16.41M
$0.00 on a plan · $24.64K straight out of an exercise
Sold at will
$16.38M
7 of 12 sales
Net
+$108.93M
+$108.96M against sales at will

By person

27 insiders · 126 transactions
0.2×

Joshua Riggs holds only 0.2 times base salary in stock. $139.61K of shares against $472.29K in salary for 2025.

Salary from the company's own proxy. The shares are what Joshua Riggs last reported holding, valued at $3.64, the price Common Stock, no par value was last bought or sold at on the open market here, on 27 Apr 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
BROADWOOD PARTNERS, L.P. entity
10% owner
$70.71M (46)
+$70.71M
56,862,456
$206.93M
ANDREWS RONALD ASBURY
Former CEO
$42.97M (7)
+$42.97M
583,212
1.78%
$2.12M
Lineage Cell Therapeutics, Inc. entity
Previous 10% Owner
$16.28M (3)
−$16.28M
6,041,154
18.46%
$21.98M
−58.8%
PURA VIDA INVESTMENTS, LLC entity
10% owner
$8.09M (9)
$102.63K (4)
+$7.99M
8,090,202
24.72%
$29.44M
+47.5%
SMITH PATRICK W
10% owner
$2.45M (9)
+$2.45M
3,258,485
9.96%
$11.86M
+93.5%
Arno Andrew
Director
$479.98K (9)
+$479.98K
312,869
0.9561%
$1.14M
James Andrea S.
Chief Financial Officer
$345.80K (3)
+$345.80K
206,060
0.6297%
$749.87K
Levine Mitchell S
Chief Financial Officer
$62.41K (4)
+$62.41K
87,080
0.2661%
$316.89K
Gutfreund John Peter
Former Director
$47.98K (2)
+$47.98K
715,000
2.18%
$2.60M
−64.0%
Redmond Cavan M.
Director
$47.56K (2)
+$47.56K
120,863
0.3693%
$439.83K
Kalajian Tony T
Sr.VP/Chief Accounting Officer
$26.33K (2)
+$26.33K
15,000
0.0458%
$54.59K
Ross Douglas T.
Former CSO
$21.00K (1)
+$21.00K
234,114
0.7154%
$851.96K
Paulsen Gisela
Former President and COO
$19.77K (1)
+$19.77K
366,500
1.12%
$1.33M
Last Andrew J.
Director
$17.40K (2)
+$17.40K
58,752
0.1795%
$213.80K
Riggs Josh
CEO and President
$10.00K (1)
+$10.00K
38,365
0.1172%
$139.61K
+33,261%
GRIFFITH MELINDA
Director
$10.00K (1)
+$10.00K
30,000
0.0917%
$109.17K
Carter Jennifer L.
Director
$9.98K (1)
+$9.98K
30,500
0.0932%
$110.99K
Yu Li
VP Cntrllr/Prncpl Acctng Offcr
$9.27K (1) scheduled
−$9.27K
16,872
0.0516%
$61.40K
KINGSLEY ALFRED D
Director
$23.27K (4)
$15.37K (4) scheduled
+$7.90K
601,990
1.84%
$2.19M
+46.9%
Parker Albert P
COO
$6.65K (1)
+$6.65K
10,586
0.0323%
$38.52K
ANNETT WILLIAM
President and CEO
(1)
$0.00
3,500
0.0107%
$12.74K
HESTERBERG LYNDAL K.
CSO
(1)
$0.00
7,477
0.0228%
$27.21K
BAILEY DON M
Director
247,001
0.7548%
$898.86K
0.0%
John Anish M.
Chief Financial Officer
150,000
0.4584%
$545.87K
SILVERMAN LOU
Director
55,807
0.1705%
$203.09K
Sundar Padmavathi
Chief Commercial Officer
4,177
0.0128%
$15.20K
Liu James Yang
VP ACCT, Cntlr, Treasurer, PAO
3,711
0.0113%
$13.50K
Insider
Date
Role
Action
Shares
Price
Amount
BROADWOOD PARTNERS, L.P.
27 Apr 2026
10% owner
Buy indirect
0
$0.00
$0.00
BROADWOOD PARTNERS, L.P.
27 Apr 2026
10% owner
Buy
250,923
$3.64
$913.13K
BROADWOOD PARTNERS, L.P.
24 Apr 2026
10% owner
Buy indirect
0
$0.00
$0.00
BROADWOOD PARTNERS, L.P.
24 Apr 2026
10% owner
Buy
38,880
$3.53
$137.08K
BROADWOOD PARTNERS, L.P.
23 Apr 2026
10% owner
Buy indirect
0
$0.00
$0.00
BROADWOOD PARTNERS, L.P.
23 Apr 2026
10% owner
Buy
280,381
$3.50
$982.03K
BROADWOOD PARTNERS, L.P.
20 Apr 2026
10% owner
Buy indirect
0
$0.00
$0.00
BROADWOOD PARTNERS, L.P.
20 Apr 2026
10% owner
Buy
40,690
$3.88
$157.97K
BROADWOOD PARTNERS, L.P.
17 Apr 2026
10% owner
Buy indirect
0
$0.00
$0.00
BROADWOOD PARTNERS, L.P.
17 Apr 2026
10% owner
Buy
40,114
$3.57
$143.25K
BROADWOOD PARTNERS, L.P.
16 Apr 2026
10% owner
Buy indirect
0
$0.00
$0.00
BROADWOOD PARTNERS, L.P.
16 Apr 2026
10% owner
Buy
102,057
$3.45
$351.66K
BROADWOOD PARTNERS, L.P.
10 Feb 2026
10% owner
Buy indirect
0
$0.00
$0.00
BROADWOOD PARTNERS, L.P.
10 Feb 2026
10% owner
Buy
521,739
$5.75
$3.00M
SMITH PATRICK W
7 Feb 2025
10% owner
Buy indirect
1,077,600
$2.05
$2.21M
James Andrea S.
7 Feb 2025
Chief Financial Officer
Buy
97,561
$2.05
$200.00K
BROADWOOD PARTNERS, L.P.
6 Feb 2025
10% owner
Buy indirect
0
$0.00
$0.00
BROADWOOD PARTNERS, L.P.
6 Feb 2025
10% owner
Buy
4,505,488
$2.05
$9.24M
BROADWOOD PARTNERS, L.P.
6 Feb 2025
10% owner
Buy indirect
0
$0.00
$0.00
BROADWOOD PARTNERS, L.P.
6 Feb 2025
10% owner
Buy
660,207
$2.05
$1.35M
SMITH PATRICK W
4 Feb 2025
10% owner
Buy indirect
25
$2.02
$50.50
SMITH PATRICK W
31 Jan 2025
10% owner
Buy indirect
890
$2.01
$1.79K
SMITH PATRICK W
30 Jan 2025
10% owner
Buy indirect
318
$2.01
$639.18
SMITH PATRICK W
29 Jan 2025
10% owner
Buy indirect
3,880
$2.01
$7.80K
SMITH PATRICK W
14 Jan 2025
10% owner
Buy indirect
10,286
$2.15
$22.11K
SMITH PATRICK W
14 Jan 2025
10% owner
Buy indirect
100
$2.08
$208.00
SMITH PATRICK W
13 Jan 2025
10% owner
Buy indirect
5,669
$2.08
$11.79K
Arno Andrew
26 Dec 2024
Director
Buy
12,500
$2.11
$26.35K
SMITH PATRICK W
26 Dec 2024
10% owner
Buy indirect
90,219
$2.13
$192.17K
James Andrea S.
5 Dec 2024
Chief Financial Officer
Buy
20,000
$2.29
$45.80K
BROADWOOD PARTNERS, L.P.
2 Oct 2024
10% owner
Buy indirect
0
$0.00
$0.00
BROADWOOD PARTNERS, L.P.
2 Oct 2024
10% owner
Buy
1,315,339
$2.95
$3.88M
James Andrea S.
2 Oct 2024
Chief Financial Officer
Buy
33,670
$2.97
$100.00K
Arno Andrew
11 Apr 2024
Director
Buy
33,898
$2.95
$100.00K
Riggs Josh
11 Apr 2024
CEO and President
Buy
3,390
$2.95
$10.00K
BROADWOOD PARTNERS, L.P.
11 Apr 2024
10% owner
Buy indirect
0
$0.00
$0.00
BROADWOOD PARTNERS, L.P.
11 Apr 2024
10% owner
Buy
2,420,000
$2.92
$7.06M
KINGSLEY ALFRED D
14 Jun 2023
Director
Buy
30,000
$0.21
$6.45K
PURA VIDA INVESTMENTS, LLC
5 Apr 2023
10% owner
Buy indirect
663,000
$0.30
$200.03K
BROADWOOD PARTNERS, L.P.
3 Apr 2023
10% owner
Buy indirect
0
$0.00
$0.00
BROADWOOD PARTNERS, L.P.
3 Apr 2023
10% owner
Buy
26,827,638
$0.30
$8.09M
Gutfreund John Peter
23 Dec 2022
Director
Buy indirect
75,000
$0.33
$24.73K
Arno Andrew
23 Dec 2022
Director
Buy
250,000
$0.35
$87.88K
KINGSLEY ALFRED D
22 Dec 2022
Director
Buy
25,000
$0.29
$7.13K
Arno Andrew
17 Aug 2022
Director
Buy indirect
7,500
$0.90
$6.75K
Arno Andrew
17 Aug 2022
Director
Buy indirect
7,500
$0.90
$6.75K
Last Andrew J.
17 Aug 2022
Director
Buy
20,000
$0.87
$17.40K
Arno Andrew
16 Aug 2022
Director
Buy
115,523
$0.97
$112.06K
Carter Jennifer L.
16 Aug 2022
Director
Buy
10,500
$0.95
$9.98K
GRIFFITH MELINDA
16 Aug 2022
Director
Buy
10,000
$1.00
$10.00K
ANDREWS RONALD ASBURY
16 Aug 2022
President & CEO
Buy
40,000
$0.96
$38.40K
Arno Andrew
15 Aug 2022
Director
Buy
34,477
$0.93
$32.06K
Gutfreund John Peter
15 Aug 2022
Director
Buy indirect
25,000
$0.93
$23.25K
KINGSLEY ALFRED D
15 Aug 2022
Director
Buy
5,000
$0.97
$4.85K
KINGSLEY ALFRED D
15 Aug 2022
Director
Buy
5,000
$0.97
$4.85K
PURA VIDA INVESTMENTS, LLC
24 Jun 2022
10% owner
Sell indirect
40,464
$1.03
$41.55K
PURA VIDA INVESTMENTS, LLC
24 Jun 2022
10% owner
Sell indirect
12,517
$1.05
$13.16K
PURA VIDA INVESTMENTS, LLC
24 Jun 2022
10% owner
Sell indirect
35,441
$1.03
$36.39K
PURA VIDA INVESTMENTS, LLC
24 Jun 2022
10% owner
Sell indirect
10,964
$1.05
$11.53K
Yu Li
18 May 2022
VP Cntrllr/Prncpl Acctng Offcr
Sold after exercise
8,128
$1.14
$9.27K
BROADWOOD PARTNERS, L.P.
14 Apr 2022
10% owner
Buy indirect
0
$0.00
$0.00
BROADWOOD PARTNERS, L.P.
14 Apr 2022
10% owner
Buy
6,003,752
$1.33
$8.00M
PURA VIDA INVESTMENTS, LLC
14 Apr 2022
10% owner
Buy indirect
1,381,438
$1.33
$1.84M
PURA VIDA INVESTMENTS, LLC
14 Apr 2022
10% owner
Buy indirect
767,952
$1.33
$1.02M
PURA VIDA INVESTMENTS, LLC
14 Apr 2022
10% owner
Buy indirect
57,630
$1.26
$72.61K
PURA VIDA INVESTMENTS, LLC
14 Apr 2022
10% owner
Buy indirect
19,210
$1.23
$23.57K
PURA VIDA INVESTMENTS, LLC
14 Apr 2022
10% owner
Buy indirect
1,916,419
$1.33
$2.55M
PURA VIDA INVESTMENTS, LLC
14 Apr 2022
10% owner
Buy indirect
92,370
$1.26
$116.39K
PURA VIDA INVESTMENTS, LLC
14 Apr 2022
10% owner
Buy indirect
30,790
$1.23
$37.78K
PURA VIDA INVESTMENTS, LLC
14 Apr 2022
10% owner
Buy indirect
1,665,898
$1.33
$2.22M
Ross Douglas T.
25 Mar 2022
Chief Scientific Officer
Buy
15,000
$1.40
$21.00K
Paulsen Gisela
17 Mar 2022
Chief Operating Officer
Buy
16,500
$1.20
$19.77K
Redmond Cavan M.
16 Mar 2022
Director
Buy
40,000
$1.19
$47.56K
ANDREWS RONALD ASBURY
16 Mar 2022
Chief Executive Officer
Buy
50,000
$1.28
$64.15K
Levine Mitchell S
15 Mar 2022
Chief Financial Officer
Buy
25,000
$1.17
$29.15K
BROADWOOD PARTNERS, L.P.
23 Sep 2021
10% owner
Exercised, kept
573,461
$3.15
$1.81M
Last Andrew J.
11 Jun 2021
Director
Exercised, kept
6,993
$3.00
$20.98K
ANDREWS RONALD ASBURY
19 Mar 2021
Chief Executive Officer
Buy
11,000
$4.79
$52.70K
BROADWOOD PARTNERS, L.P.
5 Feb 2021
10% owner
Buy indirect
0
$0.00
$0.00
BROADWOOD PARTNERS, L.P.
5 Feb 2021
10% owner
Buy
600,000
$4.50
$2.70M
BROADWOOD PARTNERS, L.P.
20 Jan 2021
10% owner
Buy indirect
0
$0.00
$0.00
BROADWOOD PARTNERS, L.P.
20 Jan 2021
10% owner
Buy
1,460,280
$3.42
$5.00M
KINGSLEY ALFRED D
28 Dec 2020
Director
Exercised, kept
65,271
$1.34
$87.46K
KINGSLEY ALFRED D
23 Dec 2020
Director
Sold after exercise
900
$2.55
$2.30K
KINGSLEY ALFRED D
22 Dec 2020
Director
Sold after exercise
7,652
no price
KINGSLEY ALFRED D
21 Dec 2020
Director
Sold after exercise
5,148
$2.54
$13.08K
KINGSLEY ALFRED D
21 Dec 2020
Director
Sold after exercise
30,000
no price
Levine Mitchell S
3 Aug 2020
Chief Financial Officer
Buy
10,000
$1.32
$13.20K
ANDREWS RONALD ASBURY
3 Aug 2020
Chief Executive Officer
Buy
40,000
$1.35
$53.88K
Kalajian Tony T
3 Aug 2020
Sr.VP/Chief Accounting Officer
Buy
5,000
$1.31
$6.53K
Parker Albert P
3 Aug 2020
Chief Operating Officer
Buy
5,000
$1.33
$6.65K
BROADWOOD PARTNERS, L.P.
24 Apr 2020
10% owner
Buy indirect
0
$0.00
$0.00
BROADWOOD PARTNERS, L.P.
24 Apr 2020
10% owner
Buy
1,050,000
$2.27
$2.38M
ANDREWS RONALD ASBURY
31 Mar 2020
CEO and President
Buy
18,000
$2,372.00
$42.70M
ANDREWS RONALD ASBURY
30 Mar 2020
CEO and President
Buy
27,216
$2.26
$61.45K
Lineage Cell Therapeutics, Inc.
2 Jan 2020
Previous 10% Owner
Sell
2,383,090
$2.16
$5.14M
BROADWOOD PARTNERS, L.P.
2 Jan 2020
10% owner
Buy indirect
0
$0.00
$0.00
BROADWOOD PARTNERS, L.P.
2 Jan 2020
10% owner
Buy
623,090
$2.16
$1.34M
BROADWOOD PARTNERS, L.P.
2 Jan 2020
10% owner
Buy indirect
0
$0.00
$0.00
BROADWOOD PARTNERS, L.P.
2 Jan 2020
10% owner
Buy
768,376
$2.16
$1.66M
BROADWOOD PARTNERS, L.P.
13 Nov 2019
10% owner
Buy indirect
0
$0.00
$0.00
BROADWOOD PARTNERS, L.P.
13 Nov 2019
10% owner
Buy
1,176,471
$1.70
$2.00M
Arno Andrew
17 Sep 2019
Director
Buy
50,000
$2.16
$108.13K
Kalajian Tony T
13 Sep 2019
SVP-Chief Accounting Officer
Buy
10,000
$1.98
$19.80K
Levine Mitchell S
12 Sep 2019
Chief Financial Officer
Buy
10,000
$2.01
$20.06K
BROADWOOD PARTNERS, L.P.
11 Sep 2019
10% owner
Buy indirect
0
$0.00
$0.00
BROADWOOD PARTNERS, L.P.
11 Sep 2019
10% owner
Buy
2,000,000
$1.66
$3.32M
Lineage Cell Therapeutics, Inc.
11 Sep 2019
10% owner
Sell
4,000,000
$1.66
$6.64M
Lineage Cell Therapeutics, Inc.
5 Jul 2019
10% owner
Sell
2,250,000
$2.00
$4.50M
BROADWOOD PARTNERS, L.P.
2 Jul 2019
10% owner
Buy indirect
0
$2.00
$0.00
BROADWOOD PARTNERS, L.P.
2 Jul 2019
10% owner
Buy
1,000,000
$2.00
$2.00M
BROADWOOD PARTNERS, L.P.
8 Feb 2019
10% owner
Buy indirect
0
$3.75
$0.00
BROADWOOD PARTNERS, L.P.
8 Feb 2019
10% owner
Buy
533,333
$3.75
$2.00M
Arno Andrew
26 Jul 2018
Director
Buy
52,447
no price
Last Andrew J.
26 Jul 2018
Director
Buy
6,993
no price
HESTERBERG LYNDAL K.
26 Jul 2018
Sr VP, Research & Development
Buy
874
no price
Redmond Cavan M.
26 Jul 2018
Director
Buy
52,447
no price
Levine Mitchell S
26 Jul 2018
Chief Financial Officer
Buy
3,495
no price
ANDREWS RONALD ASBURY
26 Jul 2018
Director
Buy
17,482
no price
ANNETT WILLIAM
26 Jul 2018
President and CEO
Buy
3,500
no price
BROADWOOD PARTNERS, L.P.
28 Mar 2018
10% owner
Buy indirect
0
$1.26
$0.00
BROADWOOD PARTNERS, L.P.
28 Mar 2018
10% owner
Buy
3,968,254
$1.26
$5.00M
BROADWOOD PARTNERS, L.P.
21 Jul 2017
10% owner
Exercised, kept indirect
0
$3.25
$0.00
BROADWOOD PARTNERS, L.P.
21 Jul 2017
10% owner
Exercised, kept
540,000
$3.25
$1.76M
BROADWOOD PARTNERS, L.P.
17 Feb 2017
10% owner
Exercised, kept indirect
0
$3.25
$0.00
BROADWOOD PARTNERS, L.P.
17 Feb 2017
10% owner
Exercised, kept
425,000
$3.25
$1.38M

What was left out

Form 4 filings counted 205
Amendments (4/A) skipped 9
Filings about a different issuer 0
Unreadable filings 0
Joint filings 25
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 5
Sales at will 7
Transactions with no price 9
Shares from compensation/vesting 13,756,518
Sales filed before the plan box existed 7
History held since 19 Oct 2016